ALT5 Sigma Corporation is a pharmaceutical preparations company trading on XNAS, led by CEO Antonios Isaac, with a market cap of $155.4M.
Common questions about ALT5 Sigma Corporation
ALT5 Sigma Corporation is scheduled to report earnings for Q1 2026 on May 12, 2026.
ALT5 Sigma Corporation has approximately 5 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.